Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALNY

Alnylam Pharmaceuticals Inc

Jun 09 • 04:00PM ET

297.69

+5.53 1.89 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ARGX REGN VRTX AMGN GILD BIIB BMRN ONC ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX	P/E	70.73	EPS (ttm)	4.21	Insider Own	0.43%	Shs Outstand	133.44M	Perf Week	4.04%
Market Cap	39.75B	Forward P/E	27.91	EPS next Y	10.67	Insider Trans	-12.23%	Shs Float	132.94M	Perf Month	0.89%
Enterprise Value	39.71B	PEG	0.36	EPS next Q	1.63	Inst Own	98.80%	Short Float	3.99%	Perf Quarter	-7.66%
Income	577.22M	P/S	9.27	EPS this Y	221.64%	Inst Trans	0.06%	Short Ratio	4.77	Perf Half Y	-35.02%
Sales	4.29B	P/B	36.94	EPS next Y	42.34%	ROA	12.36%	Short Interest	5.30M	Perf YTD	-25.14%
Book/sh	8.06	P/C	13.21	EPS next 5Y	78.43%	ROE	96.94%	52W High	495.55 -39.93%	Perf Year	-2.08%
Cash/sh	22.54	P/FCF	61.97	EPS past 3/5Y	- -	ROIC	15.30%	52W Low	283.10 5.15%	Perf 3Y	56.00%
Dividend Est.	-	EV/EBITDA	49.21	Sales past 3/5Y	52.98% 49.77%	Gross Margin	80.83%	Volatility	4.13% 3.44%	Perf 5Y	89.12%
Dividend TTM	-	EV/Sales	9.26	EPS Y/Y TTM	308.45%	Oper. Margin	17.54%	ATR (14)	10.81	Perf 10Y	355.11%
Dividend Ex-Date	-	Quick Ratio	3.06	Sales Y/Y TTM	82.57%	Profit Margin	13.46%	RSI (14)	49.16	Recom	1.71
Dividend Gr. 3/5Y	- -	Current Ratio	3.13	EPS Q/Q	440.32%	SMA20	0.74%	Beta	0.27	Target Price	441.58
Payout	0.00%	Debt/Eq	2.76	Sales Q/Q	96.43%	SMA50	-2.75%	Rel Volume	1.14	Prev Close	292.16
Employees	2500	LT Debt/Eq	2.51	Earnings	Apr 30 BMO	SMA200	-21.70%	Avg Volume	1.11M	Price	297.69
IPO	May 28, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	73.26% 4.63%	Trades		Volume	1,259,744	Change	1.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)